Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Income from Continuing Operations (2020 - 2025)

LifeStance Health (LFST) has disclosed Income from Continuing Operations for 6 consecutive years, with 13686000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 269.59% to 13686000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 11681000.0, a 120.0% increase, with the full-year FY2025 number at 11681000.0, up 120.0% from a year prior.
  • Income from Continuing Operations was 13686000.0 for Q4 2025 at LifeStance Health, up from 1077000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 13686000.0 in Q4 2025 to a low of 119420000.0 in Q3 2021.
  • A 5-year average of 37240100.0 and a median of 36047500.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 1463.91% in 2021, then surged 269.59% in 2025.
  • LifeStance Health's Income from Continuing Operations stood at 101723000.0 in 2021, then skyrocketed by 54.13% to 46656000.0 in 2022, then rose by 3.64% to 44959000.0 in 2023, then skyrocketed by 82.05% to 8070000.0 in 2024, then soared by 269.59% to 13686000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Income from Continuing Operations are 13686000.0 (Q4 2025), 1077000.0 (Q3 2025), and 3791000.0 (Q2 2025).